Concepedia

Gregory J. Carven

GJ

Statistics

Publications

13

Citations

1.5K

H-Index

13

Active since

1999

Affiliations

Scholar Rock (United States)(Current)

University of Massachusetts Chan Medical School

Massachusetts Institute of Technology

Pfizer (United States)

Dana-Farber Cancer Institute

Gregory J. Carven is an author at Scholar Rock (United States) specializing in life sciences, immunology, and biochemistry.

ORCID

Publications per year

1999–2024

13

Publications

13

Proteomic Analysis of Microglia-Derived Exosomes: Metabolic Role of the Aminopeptidase CD13 in Neuropeptide Catabolism

Ilaria Potolicchio, Gregory J. Carven, Xiaonan Xu et al. · The Journal of Immunology · 2005 · 363 citations

, , +16

PD-1 Blockade Augments Th1 and Th17 and Suppresses Th2 Responses in Peripheral Blood From Patients With Prostate and Advanced Melanoma Cancer

John Dulos, Gregory J. Carven, Susan J. van Boxtel et al. · Journal of Immunotherapy · 2012 · 318 citations

, , +17

Selective inhibition of TGFβ1 activation overcomes primary resistance to checkpoint blockade therapy by altering tumor immune landscape

Constance J. Martin, Abhishek Datta, Christopher Littlefield et al. · Science Translational Medicine · 2020 · 231 citations

, , +14

Extracellular antigen processing and presentation by immature dendritic cells

Laura Santambrogio, Aaron K. Sato, Gregory J. Carven et al. · Proceedings of the National Academy of Sciences · 1999 · 190 citations

, , +17

Blocking extracellular activation of myostatin as a strategy for treating muscle wasting

Michelle Pirruccello, Justin Jackson, Stefan Wawersik et al. · Scientific Reports · 2018 · 90 citations · Full text

, , +15

1–5 of 13